Loading…
Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients
The effect of rosuvastatin or atorvastatin on urinary albumin excretion (UAE) was determined in type 2 diabetic patients. A randomized, double-blind, parallel-group, response-based design compared rosuvastatin 10 mg (titrated to 40 mg) with atorvastatin 10 mg (titrated to 80 mg) in type 2 diabetic p...
Saved in:
Published in: | Diabetes research and clinical practice 2006-04, Vol.72 (1), p.81-87 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The effect of rosuvastatin or atorvastatin on urinary albumin excretion (UAE) was determined in type 2 diabetic patients. A randomized, double-blind, parallel-group, response-based design compared rosuvastatin 10
mg (titrated to 40
mg) with atorvastatin 10
mg (titrated to 80
mg) in type 2 diabetic patients with dyslipidemia, with dose titration to an LDL-C target of 20
μg/min). No significant change in GFR from baseline after 16 weeks was observed for either treatment group. These data provide reassurance that type 2 diabetic patients can be treated with higher efficacy statins without clinically meaningful effects on urinary albumin excretion. |
---|---|
ISSN: | 0168-8227 1872-8227 |
DOI: | 10.1016/j.diabres.2005.09.004 |